Optimal cut-off value for identifying objective response in patients with nasopharyngeal carcinoma after induction chemotherapy.
Chao LuoWenjie HuangShuqi LiHao-Jiang LiGuangying RuanGui FuLi-Zhi LiuPublished in: Head & neck (2024)
With an optimal cut-off value of 20%, RECIST may assist clinicians to accurately evaluate disease response in NPC patients.